首页> 外文会议>International Symposium on Bioinformatics Research and Applications >An Extension of Deep Pathway Analysis: A Pathway Route Analysis Framework Incorporating Multi-dimensional Cancer Genomics Data
【24h】

An Extension of Deep Pathway Analysis: A Pathway Route Analysis Framework Incorporating Multi-dimensional Cancer Genomics Data

机译:深度途径分析的延伸:一种衔接途径分析框架,包括多维癌基因组学数据

获取原文

摘要

Recent breakthroughs in cancer research have happened via the up-and-coming field of pathway analysis. By applying statistical methods to previously known gene and protein regulatory information, pathway analysis provides a meaningful way to interpret genomic data. In this paper we propose systematic methodology framework for studying biological pathways; one that cross-analyzes mutation information, transcriptome and proteomics data. Each pathway route is encoded as a bayesian network which is initialized with a sequence of conditional probabilities specifically designed to encode directionality of regulatory relationships defined by the pathways. Proteomics regulations, such as phosphorylation, is modeled by dynamically generated bayesian network through combining certain type of proteomics data to the regulated target. The entire pipeline is automated in R. The effectiveness of our model is demonstrated through its ability to distinguish real pathways from decoy pathways on TCGA mRNA-seq, mutation, copy number variation and phosphorylation data for both breast cancer and ovarian cancer study.
机译:近期癌症研究的突破通过了途径的途径分析。通过将统计方法应用于先前已知的基因和蛋白质调节信息,途径分析提供了解释基因组数据的有意义的方法。在本文中,我们提出了用于研究生物途径的系统方法框架;交叉分析突变信息,转录组和蛋白质组学数据的一个。每个通路路由被编码为贝叶斯网络,该网络被初始化,该条件概率专门设计成编码由途径定义的调节关系的方向性。蛋白质组学规定,如磷酸化,通过将某些类型的蛋白质组学数据与调节目标组合来模拟动态产生的贝叶斯网络。整个管道在R中自动化。通过其能够将实际途径从TCGA mRNA-SEQ,突变,拷贝数变异和磷酸化数据中区分真实途径,乳腺癌和卵巢癌研究的能力来证明我们的模型的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号